Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?

This publication has 33 references indexed in Scilit:

• Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids
  Rheumatology, 2006
• Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2004
• Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection
  Seminars in Arthritis and Rheumatism, 2002
• Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas
  European Journal of Immunology, 2002
• Autoimmunity and lymphoma: tribulations of B cells
  Nature Immunology, 2001
• Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
  Arthritis & Rheumatism, 2001
• Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus–associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor–producing cells that occur mainly in type II cryoglobulinemia
  Blood, 2000
• Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
  Arthritis & Rheumatism, 2000
• CRYOGLOBULINEMIA
  Hematology/Oncology Clinics of North America, 1999
• A Role for Hepatitis C Virus Infection in Type II Cryoglobulinemia
  New England Journal of Medicine, 1992